Coben pharmaceutical Co., Ltd. Coben pharmaceutical Co., Ltd.
Coben pharmaceutical Co., Ltd.
Coben pharmaceutical Co., Ltd.
·
TDF/TAF & its intermediates
·
Sofosbuvir & its intermediates
·
Gemcitabine & its intermediates
·
Cidofovir & its intermediates
·
Emtricitabine & its intermediates
·
Nirmatrelvir & its intermediates
·
Oseltamivir phosphate & its intermediates
·
Sidenafil & its intermediates
·
Tadalafil & its intermediates
·
Colesevelam & its intermediates
·
Avanafil & its intermediates

Contract manufacturing / Factory facilities & technical advantage:

More than 300 reactors with capacities range: 100-5000L(stainless and glass),
including:  High pressure reactors: with total capacity of 28 m3.
Pilot workshop: more than 20 reactors with capacities range: 100-1000L.
Three workshops of GMP standard clean: total area of 1000m2, with class 100000.
Operation condition:
(1) Reaction pressure: maximum up to 5.0MPa
(2) Reaction temperature: -70°c - +200°c
(3) Reaction maximum vacuum: ≤1mmHg
Reaction type:
(1) Grignard reaction
(2) Halogentation
(3) Reformatsky reaction
(4) Diazotization
5) Hydrongen reduction
6) Carbonylation
7) Glycosylation reaction
8) Chiral induction reaction

 
Copyright(C)2007, Coben pharmaceutical Co., Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice